Association between thromboembolic events and the JAK2 V617F mutation in myeloproliferative neoplasms.
Takata Y, Seki R, Kanajii T, Nohara M, Koteda S, Kawaguchi K, Nomura K, Nakamura T, Morishige S, Oku E, Osaki K, Hashiguchi E, Mouri F, Yoshimoto K, Nagafuji K, Okamura T.
Takata Y, et al. Among authors: oku e.
Kurume Med J. 2014;60(3-4):89-97. doi: 10.2739/kurumemedj.ms63001. Epub 2014 May 26.
Kurume Med J. 2014.
PMID: 24858412
Free article.